Ignite Creation Date:
2025-12-25 @ 5:08 AM
Ignite Modification Date:
2025-12-26 @ 4:12 AM
Study NCT ID:
NCT02229227
Status:
COMPLETED
Last Update Posted:
2020-11-27
First Post:
2014-08-28
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-11-21
Start Date Type:
ACTUAL
Primary Completion Date:
2017-07-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-07-24
Completion Date Type:
ACTUAL
First Submit Date:
2014-08-28
First Submit QC Date:
None
Study First Post Date:
2014-09-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-06-01
Results First Submit QC Date:
None
Results First Post Date:
2018-06-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-11-13
Last Update Post Date:
2020-11-27
Last Update Post Date Type:
ACTUAL